Biopulse

Biopulse Biopulse operates in the Biotechnology sector, and his main mission is the invention, the design, th

An   session with   conducted by Dr. Fowler.
26/01/2025

An session with conducted by Dr. Fowler.

Watch the complete video and interview to Dr. Megan Brown who chose the OnkoDisruptor technology to treat her pets patie...
18/09/2024

Watch the complete video and interview to Dr. Megan Brown who chose the OnkoDisruptor technology to treat her pets patients with electrochemotherapy at the Metropolitan Veterinary Hospital in Highland Heights, USA




ECT boosts the delivery of chemotherapy drugs into cancer cells, using short but intense electrical pulses.

Watch the full video and interview.Electrochemotherapy: an option to treat animals with cancer. In this article the test...
18/09/2024

Watch the full video and interview.

Electrochemotherapy: an option to treat animals with cancer. In this article the testimony of Dr. Megan Brown who chose the OnkoDisruptor technology to treat her patients at the Metropolitan Veterinary Hospital in Highland Heights, USA

https://www.msn.com/en-us/health/other/electrochemotherapy-one-more-option-for-treating-animals-with-cancer-ready-pet-go/ar-AA1gZdtL?ocid=BingNewsVerp

ECT boosts the delivery of chemotherapy drugs into cancer cells, using short but intense electrical pulses.

Veterinary Cancer Society 2023 Annual ConferenceDr. Enrico Pierluigi Spugnini presented Electrochemotherapy in veterinar...
19/10/2023

Veterinary Cancer Society 2023
Annual Conference
Dr. Enrico Pierluigi Spugnini presented Electrochemotherapy in veterinary oncology: State of the art and future perspectives

More information:
https://vetcancersociety.org/annual-conference/home/

After hosting our first Annual Conference in person in Norfolk, Virginia after two years of virtual, I am extremely excited about continuing the connections and collaborations at our 2023 Annual Conference in Reno, Nevada from October 12-14, 2023, at the beautiful Peppermill Resort.

We present a new Scientific Publication conducted with OnkoDisruptor® electroporator. Primary Peria**l Malignant Melanom...
30/03/2022

We present a new Scientific Publication conducted with OnkoDisruptor® electroporator. Primary Peria**l Malignant Melanoma in a Dog - Combination Therapy.
From Acta Scientiae Veterinariae, 2022.

🆕Primary peria**l malignant melanoma has been rarely reported in veterinary literature with unknown prognosis. This is the first case to use systemic carboplatin in an electrochemotherapy protocol as neoadjuvant treatment. Neoadjuvant ECT leaded to a reliable approach for partial remission in order to perform a better surgical approach in this case report. ECT may be an option for partial remission and local control in regions which anatomic limitation is a challenge for wide excision.

Read Article https://www.seer.ufrgs.br/ActaScientiaeVeterinariae/article/view/117948

**lMalignantMelanoma

Primary Peria**l Malignant Melanoma in a Dog - Combination Therapy Authors Ygor Amaral Rossi Resident in Veterinary Surgery, Veterinary Hospital Veterinário Universidade de Franca https://orcid.org/0000-0002-4067-2771 Leticia Ribeiro Self-employed veterinarian in Santa Clara Clinic, Garça, São Pa...

Electrochemotherapy as a treatment option for feline nasal melanoma with Onkodisruptor electroporator A study conducted ...
16/02/2022

Electrochemotherapy as a treatment option for feline nasal melanoma with Onkodisruptor electroporator

A study conducted by North Downs Specialist Refferals UK

A 4-year-old domestic shorthair cat presented to North Downs Specialist Referrals for treatment of a 7 mm melanoma of the nasal planum. Two treatments of electrochemotherapy using intravenous bleomycin as a chemotherapeutic agent were administered. The tumour was no longer visible after treatment. At the 292-day follow-up there was no recurrence at the site and the patient was clinically well.

Read the Article:
https://journals.sagepub.com/doi/full/10.1177/20551169221074231

Other Information:
www.onkodisruptor.it

Case summary A 4-year-old domestic shorthair cat presented to North Downs Specialist Referrals for treatment of a 7 mm melanoma of the nasal planum. Two treatme...

New ECT Pub with OnkoDisruptorPrimary Peria**l Malignant Melanoma in a Dog Combination Therapyhttps://www.seer.ufrgs.br/...
13/01/2022

New ECT Pub with OnkoDisruptor
Primary Peria**l Malignant Melanoma in a Dog
Combination Therapy

https://www.seer.ufrgs.br/ActaScientiaeVeterinariae/article/view/117948/0

Surgery is still the cornerstone treatment for MM in dogs, regardless anatomic site. However, in peria**l region, wide or radical local surgical excision is a challenge due to anatomic region which precluded most of the time to achieve complete margins. In this report, the origin of the tumors was not defined since no normal tissue was found surrounding tumors cells probably due to tumor invasion and destruction of surrounding tissue. Thus, based on the previous literature, this tumor could have been arisen from re**um wall or a**l sac. The longer DFI and survival time from this patient is superior from the most veterinary cases in literature which combined different types of treatment such as surgery, chemotherapy, immunotherapy, palliative care or ECT. Neoadjuvant ECT leaded to a reliable approach for partial remission in order to perform a better surgical approach in this case report. To conclude, ECT may be an option for partial remission and local control in regions which anatomic limitation is a challenge for wide excision.

Read Article
https://www.seer.ufrgs.br/ActaScientiaeVeterinariae/article/view/117948/0

Primary Peria**l Malignant Melanoma in a Dog - Combination Therapy

New life for cat after electrochemmotherapy treatment with Onkodisruptor electroporator. Acai was brought to North Downs...
16/11/2021

New life for cat after electrochemmotherapy treatment with Onkodisruptor electroporator. Acai was brought to North Downs Specialist Referrals in Bletchingley, Surrey, after he was discovered to have a squamous cell carcinoma on the underside of his tongue.

Read the Article 🔝
https://www.vettimes.co.uk/news/new-life-for-cat-given-50-days-after-novel-cancer-treatment/

Acai was brought to North Downs Specialist Referrals in Bletchingley, Surrey, after he was discovered to have a squamous cell carcinoma on the underside of his

Congratulations to our friend and collegue Dr. Denner Santos Dos Anjos for the third edition of the prestigious electro-...
09/11/2021

Congratulations to our friend and collegue Dr. Denner Santos Dos Anjos for the third edition of the prestigious electro-chemotherapy course! Thanks for your preparation and great passion from OnkoDisruptor team!

Veterinary electrochemotherapy equipment
www.onkodisruptor.com

The OnkoDisruptor® Exp Vet electroporator for veterinary electrochemotherapy is designed to ensure to the most expert ve...
26/10/2021

The OnkoDisruptor® Exp Vet electroporator for veterinary electrochemotherapy is designed to ensure to the most expert veterinary oncologists the maximum adaptability in all cases to be treated:
✔external
✔subcutaneous
✔deep / ultrasound-guided
More Information https://www.onkodisruptor.com/veterinary-electroporator/

A new meeting from Mexico to talk about veterinary electrochemotherapy held by our colleague and friend Dr. Arturo Varga...
24/09/2021

A new meeting from Mexico to talk about veterinary electrochemotherapy held by our colleague and friend Dr. Arturo Vargas.

More information about electrochemotherapy technology
www.onkodisruptor.com

Por favor llena tus datos completos y asegurate de que tu dirrección de email esta escrita correctamente y al terminar este formulario tendras disponible tu link de acceso al webinar, también se te enviará un correo electrónico de confirmación con el link.

Indirizzo

Rome
00144

Orario di apertura

Lunedì 09:00 - 18:00
Martedì 09:00 - 18:00
Mercoledì 09:00 - 18:00
Giovedì 09:00 - 18:00
Venerdì 09:00 - 18:00

Notifiche

Lasciando la tua email puoi essere il primo a sapere quando Biopulse pubblica notizie e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.

Contatta L'azienda

Invia un messaggio a Biopulse:

Condividi

Biopulse. Veterinary Oncology.

Biopulse is an Italian company mainly engaged in the medical transnational research sector. The founders of the company, Dr. Enrico Pierluigi Spugnini and Dr. Alfonso Baldi, are internationally considered to be among the leading experts in veterinary electrochemotherapy ECT and electrogenetherapy EGT, and have widely published in international medical and veterinarian journals.

Biopulse operates in the Biotechnology sector, and his main mission is the invention, the design, the manufacture and the marketing of innovative electromedical and electrotherapeutic instruments. Biopulse has realized the phase of design, construction and industrialization of an electroporation device for veterinary use: Onkodisruptor ®.

Electroporator Onkodisruptor ® must be used for veterinary adjuvant or neadjuvant electrochemotherapy ECT or for electrogenetherapy EGT in companion animals, equine, exotics and laboratory animals. This apparatus must be exclusively used under the supervision of a qualified veterinary doctor.

The device is entirely designed and manufactured in Italy with the highest quality standards. The instrument conforms to the following EU Directives (2006/95/EC regarding low voltage safety and related standard).